HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada

被引:11
作者
Choi, Yoojin [1 ]
Loutfy, Mona [2 ,3 ,4 ]
Remis, Robert S. [2 ]
Liu, Juan [5 ]
Rebbapragada, Anuradha [6 ]
Huibner, Sanja [7 ]
Brunetta, Jason [3 ]
Smith, Graham [3 ]
Reko, Tatjana [8 ]
Halpenny, Roberta [3 ]
Kaul, Rupert [1 ,7 ,9 ]
Grennan, Troy [10 ,11 ,12 ]
机构
[1] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Maple Leaf Med Clin, Toronto, ON, Canada
[4] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada
[5] Publ Hlth Ontario, Publ Hlth Lab Toronto, Toronto, ON, Canada
[6] Canada HealthLabs, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] GlaxoSmithKline, Mississauga, ON, Canada
[9] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[10] BC Ctr Dis Control, Vancouver, BC, Canada
[11] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[12] St Pauls Hosp, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; HIV-UNINFECTED MEN; PREVALENCE; PERSISTENCE; VACCINE; CANCER; PENILE; ANUS; GAY;
D O I
10.1038/s41598-021-84079-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Men who have sex with men (MSM) are disproportionately affected by anal cancer, predominantly caused by high-risk (HR) human papillomavirus (HPV) infection. Currently, the nonavalent HPV vaccine provides coverage against nine HPV genotypes, including seven HR-HPV genotypes. Here, we characterize anal HR-HPV genotype distribution and associated risk factors in MSM from Toronto, Canada recruited between September 2010 and June 2012. Wilcoxon-Mann-Whitney test was used for continuous variables, Chi-square test was performed for categorical variables, and a multivariable model using logistic regression was created to assess for correlates of anal HR-HPV infection. A total of 442 MSM were recruited, with a median age of 45 (IQR 38-50) and an overall HPV prevalence of 82%. The prevalence of any HR-HPV infection was 65.3% and 50.7% in the HIV-positive and HIV-negative MSM, respectively. No participant tested positive for all genotypes covered by the nonavalent vaccine. HIV status (aOR 1.806; 95% CI 1.159-2.816), smoking (aOR 2.176; 95% CI 1.285-3.685) and the number of lifetime sexual partners (aOR 2.466; 95% CI 1.092-5.567) were independent risk factors for anal HR-HPV infection. Our findings will be useful to inform HPV vaccine rollout and HPV prevention strategies in Canadian MSM.
引用
收藏
页数:10
相关论文
共 39 条
[1]   Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis [J].
Beachler, Daniel C. ;
Jenkins, Gwendolyne ;
Safaeian, Mahboobeh ;
Kreimer, Aimee R. ;
Wentzensen, Nicolas .
JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (09) :1444-1454
[2]   Immunogenicity and safety of the 9-valent HPV vaccine in men [J].
Castellsague, X. ;
Giuliano, A. R. ;
Goldstone, S. ;
Guevara, A. ;
Mogensen, O. ;
Palefsky, J. M. ;
Group, T. ;
Shields, C. ;
Liu, K. ;
Maansson, R. ;
Luxembourg, A. ;
Kaplan, S. S. .
VACCINE, 2015, 33 (48) :6892-6901
[3]   A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic [J].
Chiao, EY ;
Krown, SE ;
Stier, EA ;
Schrag, D .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (04) :451-455
[4]   Strategies for Screening and Early Detection of Anal Cancers: A Narrative and Systematic Review and Meta-Analysis of Cytology, HPV Testing, and Other Biomarkers [J].
Clarke, Megan A. ;
Wentzensen, Nicolas .
CANCER CYTOPATHOLOGY, 2018, 126 (07) :447-460
[5]   Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review [J].
Corral, J. ;
Pares, D. ;
Garcia-Cuyas, F. ;
Revollo, B. ;
Videla, S. ;
Chamorro, A. ;
Pinol, M. ;
Clotet, B. ;
Sirera, G. .
TECHNIQUES IN COLOPROCTOLOGY, 2019, 23 (08) :707-712
[6]   Cross-roads in the classification of papillomaviruses [J].
de Villiers, Ethel-Michele .
VIROLOGY, 2013, 445 (1-2) :2-10
[7]   Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis [J].
De Vuyst, Hugo ;
Clifford, Gary M. ;
Nascimento, Maria Claudia ;
Madeleine, Margaret M. ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (07) :1626-1636
[8]   Prevalence, genotype diversity and determinants of anal HPV infection in HIV-uninfected men having sex with men [J].
Dona, Maria Gabriella ;
Palamara, Guido ;
Di Carlo, Aldo ;
Latini, Alessandra ;
Vocaturo, Amina ;
Benevolo, Maria ;
Pimpinelli, Fulvia ;
Giglio, Amalia ;
Moretto, Domenico ;
Impara, Giampaolo ;
Giuliani, Massimo .
JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (02) :185-189
[9]   Seroconversion following anal and genital HPV infection in men: The HIM study [J].
Giuliano, Anna R. ;
Viscidi, Raphael ;
Torres, B. Nelson ;
Ingles, Donna J. ;
Sudenga, Staci L. ;
Villa, Luisa L. ;
Baggio, Maria Luiza ;
Abrahamsen, Martha ;
Quiterio, Manuel ;
Salmeron, Jorge ;
Lazcano-Ponce, Eduardo .
PAPILLOMAVIRUS RESEARCH, 2015, 1 :109-115
[10]   Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians' challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men [J].
Grace, Daniel ;
Gaspar, Mark ;
Rosenes, Ron ;
Grewal, Ramandip ;
Burchell, Ann N. ;
Grennan, Troy ;
Salit, Irving E. .
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2019, 18 (01)